# Mosunetuzumab-Market-Report
Industry revenue for Mosunetuzumab is estimated to rise to $783.0 million by 2035 from $360.7 million of 2024. The revenue growth of market players is expected to average at 7.3% annually for the period 2024 to 2035.
